These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21659620)

  • 1. Role of integrins in fibrosing liver diseases.
    Patsenker E; Stickel F
    Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G425-34. PubMed ID: 21659620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines in liver diseases.
    Marra F; Bertolani C
    Hepatology; 2009 Sep; 50(3):957-69. PubMed ID: 19585655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic stellate cells in inflammation-fibrosis-carcinoma axis.
    Wang BB; Cheng JY; Gao HH; Zhang Y; Chen ZN; Bian H
    Anat Rec (Hoboken); 2010 Sep; 293(9):1492-6. PubMed ID: 20652939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P; Yee HF
    Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene regulation in hepatic stellate cell.
    Lang A; Brenner DA
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):173-9. PubMed ID: 10363203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of integrins in the physiologic and pathogenic processes].
    Borowska K; Jedrych B; Czerny K; Zabielski S
    Pol Merkur Lekarski; 2006 Oct; 21(124):362-6. PubMed ID: 17205779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histomorphological study of the relation between mast cells and liver disease].
    Leone G; Sansonno DE; Manghisi OG
    Minerva Med; 1986 Jan; 77(3-4):113-8. PubMed ID: 3945415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis.
    Akyol G; Erdem O; Yilmaz G
    Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in chronic liver disease and its complications.
    Coulon S; Heindryckx F; Geerts A; Van Steenkiste C; Colle I; Van Vlierberghe H
    Liver Int; 2011 Feb; 31(2):146-62. PubMed ID: 21073649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts in the pathogenesis of alcoholic liver disease.
    Albano E
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):749-59. PubMed ID: 19090736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis.
    Rombouts K; Marra F
    Dig Dis; 2010; 28(1):229-35. PubMed ID: 20460917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
    Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokines in liver inflammation and fibrosis.
    Wasmuth HE; Tacke F; Trautwein C
    Semin Liver Dis; 2010 Aug; 30(3):215-25. PubMed ID: 20665374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel factors playing a role in the pathomechanism of diffuse liver diseases: apoptosis and hepatic stem cells].
    Schaff Z; Nagy P
    Orv Hetil; 2004 Aug; 145(35):1787-93. PubMed ID: 15493221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the beta 1 chain (CD29) of integrins and CD45 in alcoholic liver disease. The VA Cooperative Study Group No. 275.
    Chedid A; Mendenhall CL; Moritz TE; French SW; Chen TS; Morgan TR
    Am J Gastroenterol; 1993 Nov; 88(11):1920-7. PubMed ID: 7694454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stellate reticuloendotheliocytes in cirrhosis of the liver].
    Aruin LI; Loginov AS; Shatalova OL
    Arkh Patol; 1987; 49(3):31-7. PubMed ID: 3593004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice.
    Shigekawa M; Takehara T; Kodama T; Hikita H; Shimizu S; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Hayashi N
    Biochem Biophys Res Commun; 2011 Mar; 406(4):614-20. PubMed ID: 21356197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.